US Patent Issued to University of Maryland, Baltimore on June 23 for "Modulation of mTORCI activity and autophagy via CIB2-RHEB interaction" (Maryland Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,385, issued on June 23, was assigned to University of Maryland, Baltimore (Baltimore).

"Modulation of mTORCI activity and autophagy via CIB2-RHEB interaction" was invented by Zubair M. Ahmed (Ellicott City, Md.), Saumil Sethna (Baltimore) and Saima Riazuddin (Ellicott City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for down-regulating mTORC1 signaling in a subject, comprising administering to the subject an effective amount of one or more compositions that promote increased levels or activity of CIB2 or a biologically active fragment or variant thereof in the subject."

The patent was filed on Au...